BioCatalyst

SYRE — Spyre Therapeutics, Inc. catalysts

1 verified catalyst event(s) for Spyre Therapeutics, Inc. (ticker SYRE). Each is linked to its official source. Verified as of 2026-06-22.

Next verified catalyst

2026-10-31 — A Study of SPY072 in Rheumatic Disease · official source ↗

Upcoming

DateEventCompanyDrugOfficial source & verification
2026-10-31
in 4mo
ESTIMATED
 READOUT
A Study of SPY072 in Rheumatic Disease
Phase 2 · Rheumatoid Arthritis, Psoriatic Arthritis
 SYRE Spyre Therapeutics, Inc. SPY002-072 ClinicalTrials.gov ↗
✓ Source-checked 2026-06-22
Sponsor-projected date — can change
Disclaimer. Bio Catalyst Calendar is a public-events data calendar. Every date is sourced and linked to an official record (ClinicalTrials.gov, FDA / Federal Register, openFDA). It is scheduling and reference data only — NOT investment advice, a recommendation, or a buy/sell signal. Dates set by sponsors and the FDA can change; always confirm against the linked official source.